Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Aldosterone antagonism in diastolic heart failure.

Trial Profile

Aldosterone antagonism in diastolic heart failure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Aug 2018

At a glance

  • Drugs Eplerenone (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 07 Sep 2011 Additional lead trial investigator identified as reported by ClinicalTrials.gov.
    • 03 Jun 2008 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top